A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The majority of companion diagnostics are for oncology treatment. Gen Consulting Company predicts that the global companion diagnostics market is estimated to touch a valuation of USD 9,659 百万, 复合年增长率为 13.2% 在预测期内 (2022-2028).

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into global companion diagnostics market. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the companion diagnostics industry.

该行业报告提供了全球市场的市场估计和预测, 接下来是对该技术的详细分析, 解决方案, 类型, 应用, 和地区. The global market for companion diagnostics can be segmented by technology: immunohistochemistry (IHC), polymerase chain reaction (聚合酶链式反应), in situ hybridization (ISH), next-generation sequencing (NGS), 其他的. 据研究, the NGS segment had the largest share in the global companion diagnostics market. Companion diagnostics market is further segmented by solution: 消耗品, 仪器. Based on type, the companion diagnostics market is segmented into: commercial CDx, lab-developed tests (LDTs) CDx. 根据应用, the companion diagnostics market also can be divided into: 肿瘤学, non-oncology, 其他的. The oncology segment captured the largest share of the market in 2021. Companion diagnostics market by region is categorized into: 亚太地区, 欧洲, 北美, 世界其他地区 (排).

按技术:
– immunohistochemistry (IHC)
– polymerase chain reaction (聚合酶链式反应)
– in situ hybridization (ISH)
– next-generation sequencing (NGS)
– 其他的

按解决方案:
– 消耗品
– 仪器

按类型:
– commercial CDx
– lab-developed tests (LDTs) CDx

按申请:
– 肿瘤学
– non-oncology
– 其他的

按地区:
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)

The oncology market is further segmented into lung cancer, 乳腺癌, colorectal cancer, 白血病, melanoma, gastric cancer, 其他的.

The report explores the recent developments and profiles of key vendors in the Global Companion Diagnostics Market, 包括雅培实验室, 公司, 安捷伦科技, 公司, Almac Group Ltd., ARUP Laboratories, 公司, bioMerieux SA, 丹纳赫公司, F. 霍夫曼-拉罗氏有限公司, Guardant Health, 公司, ICON plc, 照明公司, 公司, Invivoscribe Technologies, 公司, Laboratory Corporation of America Holdings (Labcorp), Luminex Corporation, Myriad Genetics, 公司, NG Biotech, SAS, Novogene Co., 有限公司, 凯杰公司, Quest Diagnostics Incorporated, Siemens Healthineers AG, Sysmex Corporation, 赛默飞世尔科技, 公司, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
– To analyze and forecast the market size of the global companion diagnostics market.
– To classify and forecast the global companion diagnostics market based on technology, 解决方案, 类型, 应用, 地区.
– To identify drivers and challenges for the global companion diagnostics market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global companion diagnostics market.
– To identify and analyze the profile of leading players operating in the global companion diagnostics market.

为什么选择这份报告
– Gain a reliable outlook of the global companion diagnostics market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.